| Published August 28, 2017

Elon Musk pulls millions into biotech companies

Multi-tasker and multi-billionaire Elon Musk is not only developing electric cars, new concepts for colonizing Mars, and hyperfast tunnel trains. He also plans to improve the human brain with the help of technological innovations. So far, he has brought on board at least a dozen investors for his bold plans, who have collectively pumped $27 million in venture capital into Musk's biotech company Neuralink, Boston-based news service STAT reports.

In wider circles, Elon Musk perhaps best known as the charismatic CEO and public face of the Nasdaq-listed electric car manufacturer Tesla, as well as for its globally recognized development projects in space traffic (space-X), in the transport sector (hyperloops) and in the development of artificial intelligence (OpenAI).
Not many people may know that Musk also founded and is CEO of Neuralink – a biotechnology company that develops electronic brain implants, or more specifically "implantable brain-computer interfaces". In the short term, the company's goal is to develop micro-sized technological aids to treat serious diseases and injuries that affect the brain. In the long term, the plans are more ambitious: to create the conditions for improving our cognitive abilities through a direct connection between computers and the human brain – to use computing power to make us smarter, simply put.
Historically, Elon Musk has repeatedly shown that he has the ability to deliver concrete results even on the most lofty visions. Something that should have made it easier for Neuralink in the hunt for venture capital. In a recently completed first so-called Series A investment round, twelve investors reportedly together have poured in $27 million, equivalent to approximately SEK 216 million, into the company.
In total, the company plans to raise an additional $73 million to develop what Elon Musk calls a “neural lace", a microscopic network of small electrodes to be transplanted into people's brains. Primarily to treat brain damage and disease, but eventually with the aim of creating human "cyborgs" with increased intelligence.
Elon Musk himself has said that a usable form of the technology is “four or five years away.” Perhaps that’s a statement that should be taken with a pinch of salt. A quick look at the company’s website reveals that it is currently recruiting “extraordinarily competent engineers and researchers.” However, a neuroscience background or expertise is not a requirement according to the text, but “talent and strong drive matter more.”
For applicants with the right qualities, in addition to generous financial compensation and an option program, the opportunity to “change the world and work with some of the smartest people you will ever meet” is offered.
Interested candidates can read more about the job openings at Neuralink. here.